Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis

BACKGROUND: Therapeutic angiogenesis with vascular endothelial growth factor (VEGF), delivered either via recombinant protein infusion or via gene therapy, has shown promise in preclinical models of various diseases including myocardial infarction, renovascular disease, preeclampsia, and neurodegene...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Eric M, Liu, Huiling, Robinson, Grant G, Mahdi, Fakhri, Perkins, Eddie, Bidwell, Gene L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316602/
https://www.ncbi.nlm.nih.gov/pubmed/25653833
http://dx.doi.org/10.1186/s13221-014-0026-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316602/
https://www.ncbi.nlm.nih.gov/pubmed/25653833
http://dx.doi.org/10.1186/s13221-014-0026-3

Ejemplares similares